GeorgiaSyrnioti United States

• EMBOLIZATION AND ADMINISTRATION OF COAGULATION FACTORS IN COMPLEX TREATMENT OF RECURRENT EROSIVE BLEEDING IN PANCREATIC NECROSIS
  211-01
  AlexeySevertsev Speaker Russia
• INTRADUCTAL PAPILLARY NEOPLASM OF THE BILE DUCT (IPNB): A RARE CASE FROM A WESTERN COUNTRY
  211-04
  RitaBanza Speaker Portugal
• THELDENIYA US GUIDED MINI INCISION CHOLECYSTECTOMY; A NEW TECHNIQUE OF CHOLECYSTECTOMY THROUGH A 5CM INCISION; WITH THE USE OF A WOUND RETRACTOR DEVICE AND ULTRASONIC GUIDANCE
  211-05
  KosalaSomaratne Speaker Sri Lanka
• RACIAL/ETHNIC DISPARITIES AND OUTCOMES OF PATIENTS WITH PANCREATIC CANCER- DATA FROM A SAFETY-NET HOSPITAL
  211-06
  GeorgiaSyrnioti Speaker United States

• ARM LYMPHEDEMA RATES IN BREAST CANCER PATIENTS WITH NEOADJUVANT CHEMOTHERAPY AFTER AXILLARY LYMPH NODE DISSECTION VERSUS TARGETED AXILLARY DISSECTION: A PROSPECTIVE COHORT STUDY
  225-02
  Geok HoonLim Speaker Singapore
• ONCOLOGIC SAFETY OF LIPOFILLING IN POST MASTECTOMY BREAST CANCER PATIENTS – A RETROSPECTIVE MATCHED CASE-CONTROL STUDY
  225-03
  Susanna Minna CeciliaKauhanen Speaker Finland
• MALE NIPPLE-SPARING MASTECTOMY AND AREOLAR-SPARING MASTECTOMY: A MULTI-INSTITUTIONAL REVIEW OF INDICATIONS AND OUTCOMES
  225-04
  GeorgiaSyrnioti Speaker United States
• BREAST-E: A PHOTOGRAMMETRY-BASED PREOPERATIVE METHOD FOR QUANTITATIVE BREAST MORPHOMETRIC ANALYSIS AND VOLUME ESTIMATION IN RECONSTRUCTIVE SURGER
  225-05
  Mee-HoongSee Speaker Malaysia
• MANAGEMENT OF RADIAL SCAR AND COMPLEX SCLEROSING LESIONS OF THE BREAST: TO EXCISE OR NOT TO EXCISE? A RETROSPECTIVE STUDY
  225-06
  NicholasZakem Speaker Canada

• INTEGRATING PERSONAL, HEREDITARY, AND POLYGENIC PROFILES VIA DEEP LEARNING-BASED RISK ESTIMATION FOR PRECLINICAL BREAST CANCER DIAGNOSIS
  3103-01
  SaturninoDomínguez Speaker Panama
• “THE TRIPLE TROUBLE” -VIRAL MARKER POSITIVITY, TUMOR AGGRESSIVENESS, AND OPPORTUNISTIC INFECTIONS IN BREAST CANCER
  3103-02
  BharathShivalingaiah Speaker India
• THE ASSOCIATION OF BODY MASS INDEX (BMI) AND HEIGHT WITH ONCOTYPE DX SCORES IN WOMEN WITH HORMONE RECEPTOR POSITIVE HER 2 NEGATIVE BREAST CANCER IN THE NYC METROPOLITAN AREA
  3103-03
  GeorgiaSyrnioti Speaker United States
• THE IMPACT OF METABOLIC SYNDROME ON THE DIAGNOSIS OF SECOND PRIMARY TUMORS IN WOMEN TREATED FOR BREAST CANCER: A RETROSPECTIVE COHORT ANALYSIS
  3103-04
  Ambrogio PLondero Speaker Italy
• INFLUENCE OF GERIATRIC ASSESSMENT ON TREATMENT DECISIONS IN ELDERLY BREAST CANCER PATIENTS
  3103-05
  Ambrogio PLondero Speaker Italy
• MINIMALLY INVASIVE RADIOFREQUENCY ABLATION (RFA) THERAPY IN PATIENTS WITH EARLY-STAGE BREAST CANCER
  3103-08
  UhiToh Speaker Japan
• CLINICAL CHARACTERISTICS OF HER2-LOW BREAST CANCER COMPARED TO HER2-NEGATIVE BREAST CANCER
  3103-09
  Cheng-HarYip Speaker Malaysia
• ENDOSCOPIC BREAST SURGERY FOR PERSONALIZATION OF BREAST CANCER TREATMENT
  3103-11
  KojiYamashita Speaker Japan
• RE-SENTINEL NODE BIOPSY IN PATIENTS WITH IPSILATERAL BREAST CANCER RECURRENCE AFTER BREAST CONSERVING SURGERY
  3103-12
  ZhiboShao Speaker China